Sinopep-Allsino Stock Hits Day Low of CNY 28.50 Amid Price Pressure

Sinopep-Allsino Bio Pharmaceutical Co., Ltd. experienced a significant decline today, with its stock price dropping by 5.58% to reach an intraday low of CNY 28.50. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Sinopep-Allsino has seen a more pronounced downturn, with a 10.12% decrease, and its one-month performance reflects a decline of 15.3%. Year-to-date, the stock has underperformed with a drop of 24.11%, while the one-year performance shows a substantial decline of 29.23%. In comparison, the China Shanghai Composite has gained 13.33% over the past year. Key financial metrics indicate a debt-equity ratio of 0.56, with a return on equity of 15.91%. The company's price-to-earnings ratio stands at 28.00, while it has not offered any dividends. The recent trends suggest ongoing challenges for Sinopep-Allsino in maintaining its market position within the pharmaceuticals and biotechnology sector.